R. Molerón

2.2k total citations
13 papers, 97 citations indexed

About

R. Molerón is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, R. Molerón has authored 13 papers receiving a total of 97 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Surgery and 5 papers in Oncology. Recurrent topics in R. Molerón's work include Head and Neck Cancer Studies (4 papers), Glioma Diagnosis and Treatment (3 papers) and Lung Cancer Treatments and Mutations (3 papers). R. Molerón is often cited by papers focused on Head and Neck Cancer Studies (4 papers), Glioma Diagnosis and Treatment (3 papers) and Lung Cancer Treatments and Mutations (3 papers). R. Molerón collaborates with scholars based in United Kingdom, Spain and Netherlands. R. Molerón's co-authors include Jesús Romero, Alejandro de la Torre, Á. Montero, Alfredo Polo, Carmen Vallejo, Fernando Arias, José Jimeno, Isabel Millán, Juan Carlos Tercero and Rosa Magallón-Botaya and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Annals of Oncology and European Journal of Cancer.

In The Last Decade

R. Molerón

11 papers receiving 96 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Molerón United Kingdom 4 64 43 27 27 17 13 97
Laura Mazzeo Italy 7 60 0.9× 12 0.3× 25 0.9× 18 0.7× 13 0.8× 19 111
Joycelin Canavan United States 3 27 0.4× 16 0.4× 13 0.5× 19 0.7× 8 0.5× 5 64
Miranda Hughes United States 2 81 1.3× 22 0.5× 20 0.7× 18 0.7× 26 1.5× 3 113
Adrian Wai Chan Canada 5 18 0.3× 11 0.3× 14 0.5× 25 0.9× 16 0.9× 26 84
Kazuhiko Shioji Japan 6 99 1.5× 44 1.0× 31 1.1× 45 1.7× 5 0.3× 12 109
Д. Л. Ротин Russia 6 25 0.4× 32 0.7× 29 1.1× 38 1.4× 1 0.1× 45 109
ChangHoon Hahn South Korea 4 50 0.8× 27 0.6× 47 1.7× 28 1.0× 3 0.2× 10 88
Najib Lamfichekh France 7 120 1.9× 110 2.6× 56 2.1× 6 0.2× 11 0.6× 7 171
Valeria Tovazzi Italy 7 59 0.9× 8 0.2× 46 1.7× 27 1.0× 9 0.5× 13 119
Jérémie Tordo France 7 38 0.6× 22 0.5× 22 0.8× 28 1.0× 4 0.2× 24 116

Countries citing papers authored by R. Molerón

Since Specialization
Citations

This map shows the geographic impact of R. Molerón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Molerón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Molerón more than expected).

Fields of papers citing papers by R. Molerón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Molerón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Molerón. The network helps show where R. Molerón may publish in the future.

Co-authorship network of co-authors of R. Molerón

This figure shows the co-authorship network connecting the top 25 collaborators of R. Molerón. A scholar is included among the top collaborators of R. Molerón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Molerón. R. Molerón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
2.
Barlas, Raphae S., et al.. (2024). Impact of remoteness and rurality on the treatment and survival of patients with glioblastoma in the north of Scotland. World Neurosurgery X. 22. 100331–100331. 1 indexed citations
4.
Murray, Matthew J., R. Molerón, Jennifer Adamski, et al.. (2021). Vinblastine monotherapy induction prior to radiotherapy for patients with intracranial germinoma during the COVID‐19 pandemic. Pediatric Blood & Cancer. 69(1). e29359–e29359. 3 indexed citations
5.
Feeney, Laura, Matthew Beasley, Oliver Donnelly, et al.. (2021). Centralised RECIST Assessment and Clinical Outcomes with Lenvatinib Monotherapy in Recurrent and Metastatic Adenoid Cystic Carcinoma. Cancers. 13(17). 4336–4336. 14 indexed citations
6.
Molerón, R., et al.. (2021). Simultaneous double laryngeal tumours: a diagnostic and therapeutic challenge. BMJ Case Reports. 14(2). e239797–e239797. 2 indexed citations
7.
Mehanna, Hisham, Anthony Kong, A. Hartley, et al.. (2018). Cetuximab versus cisplatin in patients with HPV-positive, low risk oropharyngeal cancer, receiving radical radiotherapy. Annals of Oncology. 29. viii729–viii730. 3 indexed citations
9.
Molerón, R.. (2013). Chemoradiation: Why, what, for whom?. Reports of Practical Oncology & Radiotherapy. 18. S7–S8. 1 indexed citations
10.
Molerón, R., et al.. (2011). 8724 POSTER Fractionated Stereotactic Radiotherapy (FSRT) for Craniopharyngiomas – Clinical and Radiological Control. European Journal of Cancer. 47. S582–S582. 1 indexed citations
11.
Montero, Á., et al.. (2009). High-dose-rate (HDR) plesiotherapy with custom-made moulds for the treatment of non-melanoma skin cancer. Clinical & Translational Oncology. 11(11). 760–764. 24 indexed citations
12.
Romero, Jesús, José Jimeno, José A. López-Martín, et al.. (2008). In vitro radiosensitisation by trabectedin in human cancer cell lines. European Journal of Cancer. 44(12). 1726–1733. 20 indexed citations
13.
Torre, Alejandro de la, Fernando Arias, Alfonso Mariño, et al.. (2007). Preoperative Chemoradiotherapy for Rectal Cancer: Randomized Trial Comparing Oral Uracil and Tegafur and Oral Leucovorin Vs. Intravenous 5-Fluorouracil and Leucovorin. International Journal of Radiation Oncology*Biology*Physics. 70(1). 102–110. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026